跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Retaglip
Approved
STANDARD
Retaglip
Unison Pharmaceuticals Pvt. Ltd. (Unit I)
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1b1d21d2d464422d
Company
Unison Pharmaceuticals Pvt. Ltd. (Unit I)
Type
Standard
Approval Details
Approval Id
1b1d21d2d464422d
Drug Approval Philippines Name
Retaglip
Product Name
Retaglip
Registration Number
DRP-13143-01
Brand Name
Retaglip
Generic Name
Vildagliptin
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Unison Pharmaceuticals Pvt. Ltd. (Unit I)
Importer
Medinova Pharmaceutical Inc.
Distributor
Reta Drug
Issuance Date
28 September 2024
Expiry Date
07 December 2027
Pharmacologic Category
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1b1d21d2d464422d
Type
Standard
Back to Philippines FDA Approvals
Retaglip - Philippines FDA Drug Approval Details